| Our products are branded generic and
licensed drugs for the treatment of serious
and debilitating diseases of sub-Saharan
Africa. These include:
·
Antiretrovirals and
combinations for treating HIV AIDS
·
Broad spectrum antibacterials
against beta-lactam resistant bacterial
infections
·
Drugs for the treatment of
opportunistic infections in
immunocompromised patients, including AIDS
patients
·
Topical antiinfectives against
various skin and soft tissue infections
·
Antimalarial regimens for
combating chloroquine resistant falciparum
malaria
We will launch our products,
including a package for prevention of
maternal to fetal transmission of HIV AIDS
in 2007.
|
